MeiraGTx Holdings (MGTX) Other Working Capital Changes (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Other Working Capital Changes came in at $65000.0 in Q3 2025, up 212.07% YoY from $20828.7 in Q3 2024, and up 131.1% on a QoQ basis from -$209000.0 in Q2 2025.
Analysis
MeiraGTx Holdings (MGTX) Other Working Capital Changes (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 4 years of Other Working Capital Changes data on file, last reported at $65000.0 in Q3 2025.
- Quarterly Other Working Capital Changes rose 212.07% year-over-year to $65000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $101000.0 (up 144.49% YoY) and the FY2024 annual result came in at $16000.0, up 107.21% from the prior year.
- Other Working Capital Changes grew to $65000.0 in Q3 2025, from -$209000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $24.8 million in Q3 2024 to a low of -$10.8 million in Q2 2022.
- A 5-year average of $940050.0 and a median of -$304000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes soared 352.17% — and 2025, when it sank 226.56%.
- Tracing MGTX's Other Working Capital Changes over 4 years: stood at -$68000.0 in 2022, then retreated by 1.47% to -$69000.0 in 2023, then soared by 352.17% to $174000.0 in 2024, then tumbled by 62.64% to $65000.0 in 2025.
- The last three Other Working Capital Changes figures came in at $65000.0 (Q3 2025), -$209000.0 (Q2 2025), and $71000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2.29 Mn |
| Dec 31, 2025 | 2.29 Mn |
| Sep 30, 2025 | -413,000.00 |
| Sep 30, 2025 | -413,000.00 |
| Jun 30, 2025 | 122,000.00 |
| Jun 30, 2025 | 122,000.00 |
| Mar 31, 2025 | -1.64 Mn |
| Mar 31, 2025 | -1.64 Mn |
| Dec 31, 2024 | 3.23 Mn |
| Dec 31, 2024 | 3.23 Mn |
| Sep 30, 2024 | -18,000.00 |
| Sep 30, 2024 | -18,000.00 |
| Jun 30, 2024 | -279,000.00 |
| Jun 30, 2024 | -279,000.00 |
| Mar 31, 2024 | -626,000.00 |
| Mar 31, 2024 | -626,000.00 |
| Dec 31, 2023 | 676,000.00 |
| Dec 31, 2023 | 676,000.00 |
| Sep 30, 2023 | -702,000.00 |
| Sep 30, 2023 | -702,000.00 |